KLK3 and prostate cancer: A study showed that berberine inhibited cell proliferation and triggered cell apoptosis of 22RV1 prostate cancer cells, and downregulated the expression of androgen receptor (AR), prostate-specific antigen (PSA), COX-2 and Bcl-2, and subsequently inhibited xenograft tumor growth in vivo [110].